Falougy, M.; Taubitz, C.; Ragab, M.; Patil, A.; Jensen, J.; Hoppe, S.; Kümpers, C.; Ribbat-Idel, J.; Rades, D.; Hakim, S.G.
Prognostic Value of SOX2 and NANOG Expression in Recurrent Oral Squamous Cell Carcinoma. Cancers 2025, 17, 1181.
https://doi.org/10.3390/cancers17071181
AMA Style
Falougy M, Taubitz C, Ragab M, Patil A, Jensen J, Hoppe S, Kümpers C, Ribbat-Idel J, Rades D, Hakim SG.
Prognostic Value of SOX2 and NANOG Expression in Recurrent Oral Squamous Cell Carcinoma. Cancers. 2025; 17(7):1181.
https://doi.org/10.3390/cancers17071181
Chicago/Turabian Style
Falougy, Mohamed, Clara Taubitz, Mohab Ragab, Akshay Patil, Justus Jensen, Steffen Hoppe, Christiane Kümpers, Julika Ribbat-Idel, Dirk Rades, and Samer George Hakim.
2025. "Prognostic Value of SOX2 and NANOG Expression in Recurrent Oral Squamous Cell Carcinoma" Cancers 17, no. 7: 1181.
https://doi.org/10.3390/cancers17071181
APA Style
Falougy, M., Taubitz, C., Ragab, M., Patil, A., Jensen, J., Hoppe, S., Kümpers, C., Ribbat-Idel, J., Rades, D., & Hakim, S. G.
(2025). Prognostic Value of SOX2 and NANOG Expression in Recurrent Oral Squamous Cell Carcinoma. Cancers, 17(7), 1181.
https://doi.org/10.3390/cancers17071181
